Cutanos GmbH

Cutanos is a biotech company founded in early 2021 that uses a modular and highly flexible drug delivery system patented by the Max Planck Society - the LC-TDS-, to develop antigen-specific immunotherapies for antiviral vaccines as well as for the treatment of autoimmune diseases. The company is located in the premises of the University of Vienna and is currently funded by an international consortium of investors.